BORTEZOMIB SUN 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG

Sun Pharmaceutical Industries (Europe) B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 938a0ba0da78ffc6
Drug Cima Aemps Name: BORTEZOMIB SUN 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG
Register Number: 1161102001
Holder Company Name: Sun Pharmaceutical Industries (Europe) B.V.
Marketing Company Name: Sun Pharma Laboratorios S.L.
Holder Company Detail Path: /organization/sun-pharmaceutical-industries-europe-b-v
Authorization Date: 2020-11-04
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE
Dose: 3,5 mg
Route Of Administration: VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Sun Pharmaceutical Industries (Europe) B.V.
Company Detail Path: /organization/sun-pharmaceutical-industries-europe-b-v

BORTEZOMIB

3,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 4, 2020

Approval ID

938a0ba0da78ffc6

Type

Standard